BlossomHill Therapeutics, Inc. (BLSM) vs Phathom Pharmaceuticals, Inc. (PHAT)
A side-by-side comparison of BlossomHill Therapeutics, Inc. and Phathom Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BLSM
BlossomHill Therapeutics, Inc.
$19.00HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
PHAT
Phathom Pharmaceuticals, Inc.
$6.68HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT
Total return — BLSM vs PHAT
growth of $100 · dividends reinvested · last 1yBLSM +24.6% (+24.6%/yr)PHAT -20.1% (-20.1%/yr)BLSM compounded faster over this window
BLSM PHAT
BLSM vs PHAT: by the numbers
- •BLSM is the larger company ($553M vs $540M market cap).
- •Both run net losses; BLSM's is the smaller (0.00% vs -41.34% net margin).
Metrics side by side
Valuation
| Metric | BLSM | PHAT |
|---|---|---|
| P/S ratio | N/A | 2.25 |
Profitability
| Metric | BLSM | PHAT |
|---|---|---|
| Gross margin | 0.00% | 82.92% |
| Operating margin | 0.00% | -91.36% |
| Net margin | 0.00% | -41.34% |
| ROIC | -43.41% | -23.45% |
Growth (annualized)
| Metric | BLSM | PHAT |
|---|---|---|
| Total return CAGR (5Y) | N/A | -26.93% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.